File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: 2020 Asian Pacific Society of Cardiology Consensus Recommendations on Antithrombotic Management for High-risk Chronic Coronary Syndrome

Title2020 Asian Pacific Society of Cardiology Consensus Recommendations on Antithrombotic Management for High-risk Chronic Coronary Syndrome
Authors
KeywordsAsia-Pacific
Anticoagulant
Antiplatelet
Bleeding
Chronic coronary syndrome
Issue Date2021
PublisherRadcliffe Cardiology. The Journal's web site is located at https://www.ecrjournal.com/
Citation
European Cardiology Review, 2021, v. 16, p. E26 How to Cite?
AbstractThe unique characteristics of patients with chronic coronary syndrome (CCS) in the Asia-Pacific region, heterogeneous approaches because of differences in accesses and resources and low number of patients from the Asia-Pacific region in pivotal studies, mean that international guidelines cannot be routinely applied to these populations. The Asian Pacific Society of Cardiology developed these consensus recommendations to summarise current evidence on the management of CCS and provide recommendations to assist clinicians treat patients from the region. The consensus recommendations were developed by an expert consensus panel who reviewed and appraised the available literature, with focus on data from patients in Asia-Pacific. Consensus statements were developed then put to an online vote. The resulting recommendations provide guidance on the assessment and management of bleeding and ischaemic risks in Asian CCS patients. Furthermore, the selection of long-term antithrombotic therapy is discussed, including the role of single antiplatelet therapy, dual antiplatelet therapy and dual pathway inhibition therapy.
Persistent Identifierhttp://hdl.handle.net/10722/308088
ISSN
2023 SCImago Journal Rankings: 0.814
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorTan, JWC-
dc.contributor.authorChew, DP-
dc.contributor.authorBrieger, D-
dc.contributor.authorEikelboom, J-
dc.contributor.authorMontalescot, G-
dc.contributor.authorAko, J-
dc.contributor.authorKim, B-
dc.contributor.authorDK, QUEK-
dc.contributor.authorAitken, SJ-
dc.contributor.authorChow, CK-
dc.contributor.authorChour, S-
dc.contributor.authorTse, HF-
dc.contributor.authorKaul, U-
dc.contributor.authorFirdaus, I-
dc.contributor.authorKubo, T-
dc.contributor.authorLiew, BW-
dc.contributor.authorChong, TT-
dc.contributor.authorSin, KY-
dc.contributor.authorYeh, HI-
dc.contributor.authorBuddhari, W-
dc.contributor.authorHasan, F-
dc.contributor.authorFox, KA-
dc.contributor.authorNguyen, QN-
dc.contributor.authorLo, ST-
dc.date.accessioned2021-11-12T13:42:20Z-
dc.date.available2021-11-12T13:42:20Z-
dc.date.issued2021-
dc.identifier.citationEuropean Cardiology Review, 2021, v. 16, p. E26-
dc.identifier.issn1758-3764-
dc.identifier.urihttp://hdl.handle.net/10722/308088-
dc.description.abstractThe unique characteristics of patients with chronic coronary syndrome (CCS) in the Asia-Pacific region, heterogeneous approaches because of differences in accesses and resources and low number of patients from the Asia-Pacific region in pivotal studies, mean that international guidelines cannot be routinely applied to these populations. The Asian Pacific Society of Cardiology developed these consensus recommendations to summarise current evidence on the management of CCS and provide recommendations to assist clinicians treat patients from the region. The consensus recommendations were developed by an expert consensus panel who reviewed and appraised the available literature, with focus on data from patients in Asia-Pacific. Consensus statements were developed then put to an online vote. The resulting recommendations provide guidance on the assessment and management of bleeding and ischaemic risks in Asian CCS patients. Furthermore, the selection of long-term antithrombotic therapy is discussed, including the role of single antiplatelet therapy, dual antiplatelet therapy and dual pathway inhibition therapy.-
dc.languageeng-
dc.publisherRadcliffe Cardiology. The Journal's web site is located at https://www.ecrjournal.com/-
dc.relation.ispartofEuropean Cardiology Review-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License-
dc.subjectAsia-Pacific-
dc.subjectAnticoagulant-
dc.subjectAntiplatelet-
dc.subjectBleeding-
dc.subjectChronic coronary syndrome-
dc.title2020 Asian Pacific Society of Cardiology Consensus Recommendations on Antithrombotic Management for High-risk Chronic Coronary Syndrome-
dc.typeArticle-
dc.identifier.emailTse, HF: hftse@hkucc.hku.hk-
dc.identifier.authorityTse, HF=rp00428-
dc.description.naturelink_to_OA_fulltext-
dc.identifier.doi10.15420/ecr.2020.45-
dc.identifier.hkuros329486-
dc.identifier.volume16-
dc.identifier.spageE26-
dc.identifier.epageE26-
dc.identifier.isiWOS:000677844400001-
dc.publisher.placeUnited Kingdom-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats